Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001079973-05-000861
Filing Date
2005-12-02
Accepted
2005-12-02 16:08:29
Documents
1
Period of Report
2005-11-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 17642
  Complete submission text file 0001079973-05-000861.txt   19622
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1905 W VALLEY VISTA DR CASTLE ROCK CO 80104
Business Address 3036809583
MCGONEGAL JEFFREY (Reporting) CIK: 0001187604 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50019 | Film No.: 051241015